Showing posts with label Lancet Psychiatry. Show all posts
Showing posts with label Lancet Psychiatry. Show all posts

Thursday, August 18, 2016

Open Psychiatric Units Mean Fewer Suicides and Elopements ?!!





There is a headline making the rounds in the media about whether or not locked psychiatric units are useful in preventing suicides and "absconding" behavior in inpatient psychiatric units.  Absconding is running away before the formal discharge and in the US it is referred to as elopement.  The media handling of this article is a bit less scholarly than you might expect from the average psychiatrist reading this article.  Even media circulating to psychiatrists sends out the headlines from a news service:  "Locked psychiatric wards may mean more suicide or escape attempts." Since I have spent the majority of my career on locked psychiatric units and consider myself an expert in this area - reading the article and looking at its deficiencies comes naturally to me.

The article looks at a coalition of 22 German psychiatric hospitals and their affiliated psychiatric services.  Sixteen of the hospitals had at least one locked psychiatric unit over the course of the study.  Four hospitals had no locked wards over the course of the study.  One of the hospitals started out with no locked wards but "had to introduce locked wards for legal reasons" in November 2000. organized under a central agency that looks at quality assurance and quality management.  Twenty one of the hospitals participated in data analysis by a central quality assurance/management agency the Dokumentationsverbund Psychiatrie (DVP).  The study period ran from January 1, 1998 to December 31, 2012.  This was  an entirely retrospective analysis based on anonymized data.  During the study period there were 271,128 admissions to locked wards and 78,446 admissions to open wards.

Primary outcome variable was completed suicide and secondary outcome variables were suicide attempts during treatment, elopement without return, and elopement with return.  Some of the characteristics of the populations were described and they appear to have diagnoses similar to what might be found on inpatient units in the US with major difference - some of the primary diagnoses listed would likely not be admitted - like somatoform disorder or personality disorder as a primary diagnosis, but the study says very little about admission criteria.  On American inpatients psychiatric units pure substance use disorders are actively discriminated against, by insurers and government agencies that govern hospitalizations and in the German sample. they constitute 18-25% of the primary diagnoses.  The authors do a statistical comparison between the locked ward and open ward groups across the outcome variables.               

There are two logical flaws with the study and the researchers comment on one.

The first is generalizability of the data.  The authors seem to recognize this in their use of OECD data and the rates of psychiatric bed utilization in Germany (2.8 per 1,000 population) versus the UK (0.5 per 1,000) and the US (0.3 per 1,000)  suggesting that there is greater acuity in the populations with fewer beds and that there is a greater proportion of acutely ill patients.  The other parameter that is critical in American inpatient psychiatry is the number of aggressive and homicidal patients.  At large metropolitan hospitals units comprised almost entirely of highly aggressive patients are not unusual.  Other patients are generally considered too vulnerable to be admitted to these units.

Aggressive behavior can create near riot conditions on units like this and an unlocked door would create numerous situations leading to violent confrontations with staff.  The striking part about this comparison to the German system was that this paper left out all mention of aggression, violence and homicide suggesting that these patients were not being admitted to these hospitals.  The only line containing these words in the entire paper was in one of the references.  That makes this study impossible to compare with any set of metropolitan psychiatric units in the US.  There is the associated question of what the Germans do with their aggressive patients?  Are they sent to forensic hospitals or specialized units?  It would be very unlikely to not encounter thousands of highly aggressive patients in any American sample this large even at a time when the largest psychiatric hospitals in the country are county jails.

The second is that the implicit notion about a randomized controlled trial.  For the reason I previously mentioned it is not likely to be ethical, amenable to human subjects approval or therefore doable.  The authors suggest that being under a mandate to treat all patients in a certain geographic area reduces selection bias.  That is difficult to accept if potential for aggression and overt aggressive behavior is not an admission criteria and if it not compared between the locked and unlocked units.      

That said, what can American psychiatric units learn from the German experience?  The first and most important is that unlocked units are possible.  I worked at a facility that typically had 4 psychiatric units and when we started one unit was open.  It was a transitional unit where people were sent after their acute disorder, agitation, aggressive behavior. and suicide risk was treated but they were not quite ready for discharge.  The management of psychiatric units by business managers eventually dictated that these partially stabilized people should just be discharged - frequently when there had been an almost imperceptible improvement.  This was all based on the fallacious "dangerousness" argument by managed care companies.  They decided about 20-25 years ago that the only reason anyone should be hospitalized on an inpatient psychiatric unit was if they were dangerous to themselves or others.  That also led to locked hospital wards, if not by implication by explicit managed care feedback as in: "If the patient does not need to be on a locked unit - they don't need to be in the hospital and therefore we are denying payment for this admission."  Have these managed care tactics dumbed down inpatient treatment and adversely affected the atmosphere of these units?  Of course it has.  It has created a palpable corrections-like atmosphere in many units.  The only reason people are there is to figure a way to get out.  This reinforces the thought that the people there really don't have any problems in the first place they are just being discriminated against.  So the first lesson from Germany is to restore the running of hospitals to psychiatrists and not business managers.

The second issue is infrastructure and length of stay (LOS).  Most EU countries have significantly more psychiatric beds available to their populations.  The most likely reason is that they are not rationed (nearly out of existence) by managed care companies or the government like they have been in the US.   Lengths of stay are also significantly greater.  The interesting dimensions for comparison would be the functional status of patient at discharge as well as the therapeutic milieu in comparing German to American units.  That would require a more sophisticated research approach but it might bring some science to inpatient psychiatric care.  It would also be interesting to know if the German hospitals have state of the art specialized programs for specific conditions and whether their environment is designed to emphasize the therapeutic rather than containment aspects.

There is also the opportunity to look at the administrative aspects of these units more specifically the impact of a business management approach to a more clinical or at least less of a short term profit approach.

We have all witnessed what healthcare businesses can do to inpatient care in the US - and it is never good. 


George Dawson, MD, DFAPA


References:


1: Huber CG, Schneeberger AR, Kowalinski E, Fröhlich D, von Felten S, Walter M, Zinkler M, Beine K, Heinz A, Borgwardt S, Lang UE. Suicide risk and absconding in psychiatric hospitals with and without open door policies: a 15 year, observational study. Lancet Psychiatry. 2016 Jul 28. pii: S2215-0366(16)30168-7. doi: 10.1016/S2215-0366(16)30168-7. [Epub ahead of print] PubMed PMID: 27477886.


Friday, July 3, 2015

Lancet Psychiatry's Inconsistent Look At Conflict Of Interest
























The opening paragraphs of this editorial piece seemed promising, especially these lines:

It's not just about the money. In mental health, reputational interests exist alongside potential financial conflicts. There might also be deep-rooted interests based on professional identity. Our specialty sometimes resembles a field of conflict, or maybe some particularly ill-tempered football league—psychiatrists versus psychiatrists, psychiatrists versus psychologists, behavioural psychologists versus psychoanalysts, pill pushers versus therapists, and, as a forthcoming attraction, ICD versus DSM—a world of factionalism, rifts, ideology, personal philosophy, and ego (or should that be id?). (ref 1)

Unfortunately things rapidly fell apart after that point.  The above statements capture much of the position I have advocated on this blog from day one.  Anyone who is not aware of the purely political factors affecting some of the conflicts outlined in these sentences is extremely naive.  If anyone needs a more extensive scorecard, please refer to the graphic at this link.  On the other hand, the problem may be that I have a restrictive view of what the authors here refer to as "our specialty".  They seem to include a lot of other people than just psychiatrists.  Midwestern psychiatry may be a different culture than the rest of psychiatry.  I think we tend to view ourselves as physicians first and then psychiatrists.  We may be more comfortable talking with medical and surgical colleagues and medical knowledge is valued rather than denigrated.  We don't claim medical knowledge for the political advantage of seeming to be like other doctors.  We know a lot of medicine because we treat a lot of people with psychiatric and medical problems and consult in acute care settings.  Some of the conferences I see advertised and a few I have attended suggest to me that there are psychiatrists out there who do not have that interest in all things medical and neurological and may be more comfortable talking with non-physicians.   When I think about "our specialty",  I am thinking about those hundreds of medically oriented psychiatrists who I know who want to talk about taking care of people with severe illnesses.  People who are comfortable in hospitals and medical clinics.  People who know about the brain, labs, brain imaging, EEGs, and all things medical.

You might think that this is just another "faction" of a fractionated specialty, but it has been surprisingly seamless to me.  I trained in three major University settings in their core hospitals and affiliated Veteran's Hospitals.   When I got out, I practiced in community hospitals and clinics before coming back to a University affiliated tertiary care center.  The knowledge base of what needed to be diagnosed and treated was uniform across all of those settings.  I could expect highly competent psychiatrists available in those settings to consult with and for cross coverage.  The focus was always excellent clinical care and avoiding mistakes.  It did not resemble the confederacy of dunces described in this editorial and frequently in the popular press.  The practical issue is that practicing in acute care settings focuses the type of care that needs to be delivered.  People need to get better, and they need to get better in a hurry.   All of the debates wash out in the bright light of pragmatism.  If your plan cannot be enacted and result in clear improvements, you don't last long in that environment.  The potential complications alone will make you look bad.  The results of a clinical trial of a medication in completely healthy adults is irrelevant.

Turning the management of the world's most expensive health care system over to a for-profit industry capable of skimming hundreds of billions of dollars off the top for what amounts to a rationing scheme is a uniquely American solution, so I would not expect a lot of recognition in a British journal.  Medical journals make it seem like we are all practicing the same brand of medicine independent of cultural and political constraints.  I doubt that the editors in these situations will prove any more savvy than American editors who seem to ignore the fact that, managed care and everything that involves dwarfs the pharmaceutical industry in terms of conflicts of interest affecting the care of patients at least in the United States and that pro-managed care articles deserve at least as much scrutiny as papers written about pharmaceuticals.

The authors use about 1/3 of their space to criticize Rosenbaum's New England Journal of Medicine series on conflict of interest and the term pharmascolds.  They get one point correct, good research should not be ignored irrespective of who is funding it.  Like other critics of Rosenbaum, they wax rhetorical in their criticism and side step the numerous valid points that she makes.  They suggest that they should be focusing on a larger number of conflicts of interests ranging from the potential financial gains from various non-pharmacological innovations to "professional vendettas" but provide very little insight into how that might occur other than continuing to "question, query, probe, and interrogate" beyond the usual financial conflict disclosure.

On that procedure, I will say good luck to them and editors everywhere.  The Institute of Medicine inspired approach (2) of considering the appearance of conflict of interest and conflict of interest to be equivalent and unevenly applying that to one industry while completely ignoring the insidious effects of another has done very little to  "strike the right balance between addressing egregious cases and creating burdens that stifle relationships that advance the goals of professionalism and generate knowledge to benefit society."

There is no better example than a health care system that systematically discriminates against mental illness and addiction and does that on the basis of questionable research based on business rather than scientific principles.  The editors could start to expand their probing to spreadsheet research that looks at the purported "cost effectiveness" of managed care or collaborative care and question any associated reported quality measures.  It is always amazing how new research compares a relatively trivial case management intervention to "care as usual", when that terrible care was the product of early research on how care can be rationed.   A good starting point might be a requirement analogous to "refusing to publish non-research articles on depression from authors who have received unrelated funding from pharmaceutical companies that market antidepressant." by refusing to publish opinion pieces from opinion leaders in the business of rationing mental health services.  Refusing to publish research articles that compare rationed to less slightly rationed care would be another.

If medical research is really supposed to be generating knowledge that benefits society, where are the state-of-the-art models for psychiatric care that can set this standard?  That is what editors everywhere should be looking for.  


George Dawson, MD, DFAPA


Ref:

1:  Conflict Resolution.  The Lancet Psychiatry 2015, Volume 2, No. 7, p571, July 2015

2:  IOM (Institute of Medicine). 2009. Conflict of Interest in Medical Research, Education, and Practice. Washington, DC: The National Academies Press.